文献速递慢性肾脏病

全球疾病负担研究揭示1990至2016年慢性肾脏病流行病学趋势

Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016.
PubMed 文献 · Kidney Int · 2018-08-03

该研究利用全球疾病负担研究数据,描述1990至2016年慢性肾脏病(CKD)的发病率、患病率、死亡和伤残调整生命年(DALYs)变化。全球CKD发病率增加89%至21,328,972,患病率增加87%至275,929,799,死亡增加98%至1,186,561,DALYs增加62%至35,032,384。负担增加主要由人口增长和老龄化驱动,且分布不均。

要点

  • 全球CKD负担显著上升,主要由人口增长和老龄化驱动。
  • 63%的CKD负担集中在低和中低收入国家。
  • 部分区域糖尿病导致的CKD负担增长超出人口增长预期。

核心结论

  • 全球CKD负担显著、上升且分布不均,主要由人口扩张驱动,部分地区糖尿病 tide 显著。

研究设计与样本

  • 基于全球疾病负担研究数据和方法,分析1990至2016年CKD的发病率、患病率、死亡和DALYs。

主要发现

  • 全球CKD发病率增加89%至21,328,972(不确定区间19,100,079-23,599,380)。
  • 全球CKD患病率增加87%至275,929,799(不确定区间252,442,316-300,414,224)。
  • 全球CKD死亡增加98%至1,186,561(不确定区间1,150,743-1,236,564)。
  • 全球CKD DALYs增加62%至35,032,384(不确定区间32,622,073-37,954,350)。
  • 全球及多数GBD区域年龄标化DALY率下降,但高收入北美、中拉丁美洲、大洋洲、撒哈拉以南非洲南部和中亚例外。

临床怎么用

  • 临床应关注CKD负担的上升趋势,尤其在低和中低收入国家及糖尿病高发区域。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The last quarter century witnessed significant population growth, aging, and major changes in epidemiologic trends, which may have shaped the state of chronic kidney disease (CKD) epidemiology. Here, we used the Global Burden of Disease study data and methodologies to describe the change in burden of CKD from 1990 to 2016 involving incidence, prevalence, death, and disability-adjusted-life-years (DALYs). Globally, the incidence of CKD increased by 89% to 21,328,972 (uncertainty interval 19,100,079- 23,599,380), prevalence increased by 87% to 275,929,799 (uncertainty interval 252,442,316-300,414,224), death due to CKD increased by 98% to 1,186,561 (uncertainty interval 1,150,743-1,236,564), and DALYs increased by 62% to 35,032,384 (uncertainty interval 32,622,073-37,954,350). Measures of burden varied substantially by level of development and geography. Decomposition analyses showed that the increase in CKD DALYs was driven by population growth and aging. Globally and in most Global Burden of Disease study regions, age-standardized DALY rates decreased, except in High-income North America, Central Latin America, Oceania, Southern Sub-Saharan Africa, and Central Asia, where the increased burden of CKD due to diabetes and to a lesser extent CKD due to hypertension and other causes outpaced burden expected by demographic expansion. More of the CKD burden (63%) was in low and lower-middle-income countries. There was an inverse relationship between age-standardized CKD DALY rate and health care access and quality of care. Frontier analyses showed significant opportunities for improvement at all levels of the development spectrum. Thus, the global toll of CKD is significant, rising, and unevenly distributed; it is primarily driven by demographic expansion and in some regions a significant tide of diabetes. Opportunities exist to reduce CKD burden at all levels of development.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Xie Y, Bowe B, Mokdad AH, et al. Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018. PMID: 30078514. doi:10.1016/j.kint.2018.04.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。